All sites C00-96,D32-33,D42-43,D45-47,D76 744 89.1 1.5 4.9 0.7 3.8
Mouth, pharynx C00-14 20 98.0 1.0 - - 1.0
  Lip C00 4 100.0 - - - -
  Tongue C02 5 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 83.3 16.7 - - -
  Pharynx C01,C09-14 7 97.1 - - - 2.9
Digestive organs C15-26 154 83.4 0.1 10.5 1.3 4.7
  Oesophagus C15 9 93.6 - 6.4 - -
  Stomach C16 17 94.0 - 2.4 - 3.6
  Small intestine C17 3 93.8 - - - 6.3
  Colon C18 43 95.8 - 0.9 - 3.3
  Rectum, rectosigmoid C19-20 28 97.2 - 1.4 1.4 -
  Anus C21 0 50.0 - - 50.0 -
  Liver C22 17 69.9 - 20.5 3.6 6.0
  Gallbladder, bile ducts C23-24 5 66.7 - 29.6 - 3.7
  Pancreas C25 29 53.5 0.7 32.6 1.4 11.8
  Other digestive organs C26 3 69.2 - - 15.4 15.4
Respiratory organs C30-39 95 71.8 8.8 10.7 0.8 7.8
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 4 100.0 - - - -
  Lung, trachea C33-34 90 70.6 9.4 11.4 0.9 7.8
  Mediastinum, pleura C38 0 50.0 - - - 50.0
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 28 99.3 - - - 0.7
Skin, non-melanoma C44 47 100.0 - - - -
Mesothelioma C45 2 90.0 - - - 10.0
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 6 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 210 99.2 - 0.3 - 0.5
  Prostate C61 204 99.2 - 0.3 - 0.5
  Testis C62 5 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 75 94.4 - 4.3 0.3 1.1
  Kidney C64 26 88.5 - 9.9 - 1.5
  Bladder and urinary tract2 C65-68 48 97.5 - 1.2 0.4 0.8
Eye C69 0 50.0 - - 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 20 84.3 - 10.8 1.0 3.9
Thyroid gland C73 6 96.7 - - - 3.3
Other endocrine glands C74-75 1 75.0 - 25.0 - -
Illdefined or unknown C76,C80 13 65.1 - 20.6 3.2 11.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 65 79.1 3.4 2.5 1.8 13.2
  Hodgkin lymphoma C81 4 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 33 99.4 - 0.6 - -
  Malignant immunoproliferative diseases C88 0 - - 100.0 - -
  Myeloma and other plasma cell tumors C90 7 48.6 - 13.5 8.1 29.7
  Leukaemia C91-95 12 56.5 14.5 - 4.8 24.2
  Myelodysplastic syndromes D46 3 29.4 11.8 - - 58.8
  Myeloproliferaitive neoplasms D45,D47 4 68.2 - - - 31.8
Not included above
  Basal cell carcinoma of the skin 279 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.